BNTX (7-Benzylidenenaltrexone) is a highly selective delta1 opioid receptor antagonist. BNTX selectively antagonizes the antinociceptive activity mediated by spinal delta1 opioid receptors, and does not alter the antinociceptive effects mediated by delta2, µ or kappa opioid receptors at selective doses[1].
Molecular Weight:
429.51
CAS Number:
[129468-28-6]
Formula:
C27H27NO4
Target:
Opioid Receptor
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted
